4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-17-002520
Director bought 3,803 shares at an average $6.50 ($24,719)
- Director acquired 10,277 shares (other)
- Director acquired 3 shares (code L)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eberwein Jeffrey E. Director | 2017-09-11 | Other acquisition | +10,277 | $50.00 | $513,850 | 383,985 | I |
| Eberwein Jeffrey E. Director | 2017-10-26 | Other acquisition | +3 | $6.25 | $19 | 10,107 | I |
| Eberwein Jeffrey E. Director | 2017-10-27 | Purchase | +2,500 | $6.50 | $16,250 | 12,607 | I |
| Eberwein Jeffrey E. Director | 2017-10-30 | Purchase | +1,303 | $6.50 | $8,469 | 13,910 | I |
| Open-market purchases · 3,803 sh · avg $6.50 · $24,719 | |||||||
Loading xslF345X03/form410211002_10312017.xml…